Cite

HARVARD Citation

    Sartore‐Bianchi, A. et al. (2019). HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer. Oncologist. pp. 1395-1402. [Online]. 
  
Back to record